A few points I've noticed that seem negative;
Recognition of the total expected loss of $454,647 (including exchange rate impacts) on the reference 2 MWh Anaergia project.
We now expect to introduce Gen3 into the production environment by the end of the Financial Year 2022.
- Forums
- ASX - By Stock
- Ann: Redflow FY2021 Appendix 4E and Financial Report
A few points I've noticed that seem negative;Recognition of the...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.63M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RFX (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online